PRESS RELEASE January 5 , 202 2 Saniona (OMX: SANION), a clinical - stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual investor conferences. Details are as follows: LifeSci Partners 11th Annual Corporate Access Event (Panel

PRESS RELEASE December 2 8 , 2021 Saniona (OMX: SANION), a clinical - stage biopharmaceutical company focused on rare diseases, today announced the initiation of a Phase 2b clinical trial of Tesomet in patients with Prader-Willi syndrome (PWS). Tesomet is an investigational fixed-dose combination

PRESS RELEASE December 2 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional members of the Board of Directors and executive management team, have purchased 82,000 shares of the